EQ-5D-5L mean scores, SDs and 95% CIs
| Control group | Intervention group | |||||||
|---|---|---|---|---|---|---|---|---|
| N | Mean | SD | 95% CIs | N | Mean | SD | 95% CIs | |
| EQ-5D-5L index | ||||||||
| T0 (baseline) | 19 | 0.461 | – | 0.301 to 0.621 | 21 | 0.611 | – | 0.480 to 0.743 |
| T1 (4 weeks) | 15 | 0.494 | – | 0.291 to 0.696 | 18 | 0.643 | – | 0.459 to 0.692 |
| T2 (12 weeks) | 14 | 0.497 | – | 0.263 to 0.731 | 16 | 0.594 | – | 0.436 to 0.752 |
| T3 (20 weeks) | 13 | 0.622 | – | 0.404 to 0.840 | 17 | 0.661 | – | 0.504 to 0.818 |
| QALY | 13 | 0.219 | – | 0.139 to 0.299 | 17 | 0.241 | – | 0.188 to 0.294 |
| EQ-VAS | ||||||||
| T0 (baseline) | 19 | 77.37 | 16.45 | – | 21 | 70.62 | 27.30 | – |
| T1 (4 weeks) | 15 | 71.33 | 21.25 | – | 18 | 76.89 | 23.84 | – |
| T2 (12 weeks) | 15 | 83.67 | 17.78 | – | 16 | 74.88 | 20.17 | – |
| T3 (20 weeks) | 15 | 78.20 | 21.53 | – | 16 | 76.69 | 25.52 | – |
QALY, quality-adjusted life year; VAS, visual analogue scale.